Both Tumor endothelial marker-8 (TEM8 or ANTRX1) and capillary morphogenesis gene-2 (CMG2 or ANTXR2) play a role in tumor angiogenesis, making them potential targets for cancer therapy [83,84,85,86,87]. This evidence concerns the gene ANTXR2 and neoplasm.